Scinai Immunotherapeutics (SCNI) Leases (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Leases for 2 consecutive years, with $1.8 million as the latest value for Q4 2025.
- Quarterly Leases fell 4.76% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, down 4.76% year-over-year, with the annual reading at $1.8 million for FY2025, 4.76% down from the prior year.
- Leases hit $1.8 million in Q4 2025 for Scinai Immunotherapeutics, down from $1.9 million in the prior quarter.
- In the past five years, Leases ranged from a high of $1.9 million in Q4 2024 to a low of $1.8 million in Q4 2025.